Asia Pacific dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

List of Tables

The Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030; it is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Technological Advancements in PCR Technologies Drive Asia Pacific dPCR and qPCR Market

Polymerase chain reaction (PCR) is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations and even serves as the basis for most next-generation sequencing (NGS) preparation. Technological advances are yielding different types of PCR techniques. The use of PCR technology has now been explored into several non-conventional applications, making molecular diagnosis easier and faster. In particular, advances in digital and real-time PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Moreover, the researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon) announced the development of an ultrafast PCR technology by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by ten times compared to the previous test by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to the current test method, and it can be finished in 5 minutes. Thus, technological advancements in PCR technologies propel the Asia Pacific dPCR and qPCR market growth.

Asia Pacific dPCR and qPCR Market Overview

The Asia Pacific dPCR and qPCR market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China, India and Japan are three major contributors to the growth of the market which is driven by increasing foreign direct investments in these countries, highly skilled, efficient and large number of labor, and streamlining government policies resulting in high investments for biotechnology sector. In addition, increasing cases of infectious and chronic diseases and government and non-government initiatives are also responsible for fueling the growth of the Asia Pacific dPCR and qPCR market.

Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific dPCR and qPCR Market Segmentation

The Asia Pacific dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Asia Pacific dPCR and qPCR market is research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Genome Diagnostics Pvt Ltd, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Asia Pacific dPCR and qPCR market.

Product Code: BMIRE00029880

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
- 4.1.2 Rising Investments and Funds for Gene Synthesis
- 4.1.3 Technological Advancements in PCR Technologies
4.2 Market Restraints
- 4.2.1 High Costs of PCR Systems
- 4.2.2 Technical Limitations Associated with qPCR
4.3 Market Opportunities
- 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
4.4 Future Trends
- 4.4.1 Development of Droplet Digital PCR
4.5 Impact Analysis:

5. dPCR and qPCR Market - Asia Pacific Market Analysis

5.1 Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
6.3 Quantitative PCR
- 6.3.1 Overview
- 6.3.2 Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Digital PCR
- 6.4.1 Overview
- 6.4.2 Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Reagents & Consumables
- 7.3.1 Overview
- 7.3.2 Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
- 7.4.1 Overview
- 7.4.2 Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
- 7.5.1 Overview
- 7.5.2 Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
8.3 Research Application
- 8.3.1 Overview
- 8.3.2 Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Application
- 8.4.1 Overview
- 8.4.2 Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Asia Pacific dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
8.5 Forensic Application
- 8.5.1 Overview
- 8.5.2 Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

9.1 Overview
9.2 Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Research Laboratories and Academic Institutes
- 9.5.1 Overview
- 9.5.2 Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Forensic Laboratories
- 9.6.1 Overview
- 9.6.2 Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Clinical Research Organizations
- 9.7.1 Overview
- 9.7.2 Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific dPCR and qPCR Market - Country Analysis

10.1.1 Asia Pacific dPCR and qPCR Market, by Country
- 10.1.1.1 China
  - 10.1.1.1.1 China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.1.2 China: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.1.3 China: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.1.4 China: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.1.4.1 China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.1.5 China: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.2 Japan
  - 10.1.1.2.1 Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.2.2 Japan: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.2.3 Japan: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.2.4 Japan: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.2.4.1 Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.2.5 Japan: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.3 India
  - 10.1.1.3.1 India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.3.2 India: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.3.3 India: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.3.4 India: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.3.4.1 India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.3.5 India: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.4 Australia
  - 10.1.1.4.1 Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.4.2 Australia: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.4.3 Australia: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.4.4 Australia: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.4.4.1 Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.4.5 Australia: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.5 South Korea
  - 10.1.1.5.1 South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.5.2 South Korea: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.5.3 South Korea: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.5.4 South Korea: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.5.4.1 South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.5.5 South Korea: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.6 Rest of Asia Pacific
  - 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
  - 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
  - 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in Asia Pacific dPCR and qPCR Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Takara Bio Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Qiagen NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Standard BioTools Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lepu Medical Technology Beijing Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 F. Hoffmann-La Roche Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Agilent Technologies Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Genome Diagnostics Pvt Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms